Furthermore, the identification of vascular defects in the ThPO and MPL models of myelofibrosis raises the possibility that EndMT, increased biological activity of YAP1/TAZ and SRF-mediated changes in gene expression, but also EC cytoskeletal function, might contribute to fibrosis. The gene discussed is WWTR1; the disease is myelofibrosis.